5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide

C190H257N23O21S2 — CID 159923058

About 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide

5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide (PubChem CID 159923058) has the molecular formula C190H257N23O21S2 and a molecular weight of 3263.42 g/mol. Its IUPAC name is 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide.

Molecular Properties

• Compound Name: 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide
• PubChem CID: 159923058
• Molecular Formula: C190H257N23O21S2
• Molecular Weight: 3263.42 g/mol
• Exact Mass: 3260.92
• IUPAC Name: 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide
• SMILES: CC(C)CN(CC(C)C)C(=O)C(Cc1cncn1C)C(=O)CCc1ccc2occc2c1.CC(C)CN(CC(C)C)C(=O)C(Cc1nccn1C)C(=O)CCc1ccc2occc2c1.Cc1cc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1cc(CC(C(=O)N(C)Cc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1cc(CC(C(=O)N(Cc2ccc3occc3c2)Cc2cc(C)nn2C)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1csc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n1.Cc1nc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)cs1
• InChI: InChI=1S/C32H44N6O3.C27H38N4O3.C27H37N3O3.2C26H35N3O3.2C26H34N2O3S/c1-21(2)17-37(18-22(3)4)31(39)29(16-27-13-23(5)33-35(27)7)32(40)38(20-28-14-24(6)34-36(28)8)19-25-9-10-30-26(15-25)11-12-41-30;1-18(2)15-31(16-19(3)4)27(33)24(14-23-12-20(5)28-30(23)7)26(32)29(6)17-21-8-9-25-22(13-21)10-11-34-25;1-18(2)16-30(17-19(3)4)27(32)24(15-23-13-20(5)28-29(23)6)25(31)9-7-21-8-10-26-22(14-21)11-12-33-26;1-18(2)16-29(17-19(3)4)26(31)22(15-25-27-11-12-28(25)5)23(30)8-6-20-7-9-24-21(14-20)10-13-32-24;1-18(2)15-29(16-19(3)4)26(31)23(13-22-14-27-17-28(22)5)24(30)8-6-20-7-9-25-21(12-20)10-11-32-25;1-17(2)14-28(15-18(3)4)26(30)23(13-22-16-32-19(5)27-22)24(29)8-6-20-7-9-25-21(12-20)10-11-31-25;1-17(2)14-28(15-18(3)4)26(30)22(13-25-27-19(5)16-32-25)23(29)8-6-20-7-9-24-21(12-20)10-11-31-24/h9-15,21-22,29H,16-20H2,1-8H3;8-13,18-19,24H,14-17H2,1-7H3;8,10-14,18-19,24H,7,9,15-17H2,1-6H3;7,9-14,18-19,22H,6,8,15-17H2,1-5H3;7,9-12,14,17-19,23H,6,8,13,15-16H2,1-5H3;7,9-12,16-18,23H,6,8,13-15H2,1-5H3;7,9-12,16-18,22H,6,8,13-15H2,1-5H3
• InChIKey: NYQTZBLVHXGSKT-UHFFFAOYSA-N
• XLogP: 35.19
• TPSA: 492.82 Ų
• H-Bond Acceptors: 37
• Rotatable Bonds: 77
• Heavy Atoms: 236
• Complexity: —

Lipinski Rule of Five

3 violations

Rule	Value
MW ≤ 500	3263.42
LogP ≤ 5	35.19
H-Bond Donors ≤ 5	0
H-Bond Acceptors ≤ 10	37

Computed Properties (RDKit)

• Structural Alerts: {'alert_name': 'beta-keto/anhydride', 'substructure': 'N/A'}

Frequently Asked Questions

What is the IUPAC name of 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide?

The IUPAC name of 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide (CID 159923058) is 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide.

What is the SMILES notation for 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide?

The canonical SMILES for 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide is CC(C)CN(CC(C)C)C(=O)C(Cc1cncn1C)C(=O)CCc1ccc2occc2c1.CC(C)CN(CC(C)C)C(=O)C(Cc1nccn1C)C(=O)CCc1ccc2occc2c1.Cc1cc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1cc(CC(C(=O)N(C)Cc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1cc(CC(C(=O)N(Cc2ccc3occc3c2)Cc2cc(C)nn2C)C(=O)N(CC(C)C)CC(C)C)n(C)n1.Cc1csc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)n1.Cc1nc(CC(C(=O)CCc2ccc3occc3c2)C(=O)N(CC(C)C)CC(C)C)cs1.

What is the InChIKey of 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide?

The InChIKey is NYQTZBLVHXGSKT-UHFFFAOYSA-N. The full InChI is InChI=1S/C32H44N6O3.C27H38N4O3.C27H37N3O3.2C26H35N3O3.2C26H34N2O3S/c1-21(2)17-37(18-22(3)4)31(39)29(16-27-13-23(5)33-35(27)7)32(40)38(20-28-14-24(6)34-36(28)8)19-25-9-10-30-26(15-25)11-12-41-30;1-18(2)15-31(16-19(3)4)27(33)24(14-23-12-20(5)28-30(23)7)26(32)29(6)17-21-8-9-25-22(13-21)10-11-34-25;1-18(2)16-30(17-19(3)4)27(32)24(15-23-13-20(5)28-29(23)6)25(31)9-7-21-8-10-26-22(14-21)11-12-33-26;1-18(2)16-29(17-19(3)4)26(31)22(15-25-27-11-12-28(25)5)23(30)8-6-20-7-9-24-21(14-20)10-13-32-24;1-18(2)15-29(16-19(3)4)26(31)23(13-22-14-27-17-28(22)5)24(30)8-6-20-7-9-25-21(12-20)10-11-32-25;1-17(2)14-28(15-18(3)4)26(30)23(13-22-16-32-19(5)27-22)24(29)8-6-20-7-9-25-21(12-20)10-11-31-25;1-17(2)14-28(15-18(3)4)26(30)22(13-25-27-19(5)16-32-25)23(29)8-6-20-7-9-24-21(12-20)10-11-31-24/h9-15,21-22,29H,16-20H2,1-8H3;8-13,18-19,24H,14-17H2,1-7H3;8,10-14,18-19,24H,7,9,15-17H2,1-6H3;7,9-14,18-19,22H,6,8,15-17H2,1-5H3;7,9-12,14,17-19,23H,6,8,13,15-16H2,1-5H3;7,9-12,16-18,23H,6,8,13-15H2,1-5H3;7,9-12,16-18,22H,6,8,13-15H2,1-5H3.

What are the key properties of 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide?

5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide has a molecular weight of 3263.42 g/mol, XLogP of 35.19, 77 rotatable bonds, 0 hydrogen bond donors, and 37 hydrogen bond acceptors.

Where does this data come from?

All data for 5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(2-methyl-1,3-thiazol-4-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-N,N-bis(2-methylpropyl)-2-[(4-methyl-1,3-thiazol-2-yl)methyl]-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;N-(1-benzofuran-5-ylmethyl)-N,2-bis[(2,5-dimethylpyrazol-3-yl)methyl]-N',N'-bis(2-methylpropyl)propanediamide;N-(1-benzofuran-5-ylmethyl)-2-[(2,5-dimethylpyrazol-3-yl)methyl]-N-methyl-N',N'-bis(2-methylpropyl)propanediamide;5-(1-benzofuran-5-yl)-2-[(1-methylimidazol-2-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide;5-(1-benzofuran-5-yl)-2-[(3-methylimidazol-4-yl)methyl]-N,N-bis(2-methylpropyl)-3-oxopentanamide is sourced from PubChem (CID 159923058), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).